Naogen Pharma
  • Home
  • About Naogen Pharma
    • Our expertise
    • The Management Team
      • Sylvain Fanier, President
      • Jean-François Chatal
      • Sébastien Avila
      • Patrick Breau
      • Chantal Krezel
    • The Board of Director
      • Jean-Pierre Cabocel, chairman of the BoD
      • Philippe Cholet
      • Claude Cholet
    • The scientific committee
      • Boris Zhuikov
      • Fabien Hyafil
      • Françoise Kraeber Bodere
      • Ulli Köster
  • Nuclear cardiology imaging
    • Positron Emission Tomography
    • Detection of myocardial ischaemia
    • Radiopharmaceuticals
    • Comparison SPECT / PET
    • Lexicon
  • News and publications
  • Contact
  • English
    • French

The Board of Director

Home The Board of Director
  • Jean-Pierre Cabocel

 

  • Philippe Cholet

 

  • Claude Cholet
Publication of 09/07/2020

Extent of Myocardial Ischemia on Positron Emission Tomography and Survival Benefit with Early Revascularization

A recent clinical study performed in 322 patients  was the first randomized comparison of  the clinical effectiveness of pharmacologic stress PET with rubidium-82 or SPECT with technetium-99m in symptomatic patients…

Read more
Actualité du 03/04/2020

Naogen Pharma and Atonco announce the appointment of their new president

NANTES – March 27, 2020 – Naogen Pharma and Atonco announce today that Sylvain Fanier, Msc. EMBA, will take over from Professor Jean-François Chatal as President from March 16, 2020….

Lire l'actualité
  • Sitemap
  • Legal Notice
  • Contact
  • Agence Kalélia
  • Personal data
  • Exercise your rights
Nous utilisons des cookies pour vous garantir la meilleure expérience sur notre site web. Si vous continuez à utiliser ce site, nous supposerons que vous en êtes satisfait.OuiNonPolitique de confidentialité